SUBSCRIBE
SUBSCRIBE

IPO

Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Cholesterol Drugmaker Gemphire Files for $60 Million IPO
April 19, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Proteostasis Debuts Well-Below Expected Range But Still Raises $50 Millon in IPO
February 11, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Cancer Prevention Pharma Files for a $29 Million IPO
December 23, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Analysts Closely Watch Bay Area CytomX’s $80 Million IPO
October 8, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Nabriva, REGENXBIO, and Penumbra Set to Go Public This Week
September 14, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Bayer’s Spinoff Covestro to Go Public in Fourth Quarter
September 4, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Constellation Pharma Mulls IPO After Genentech Declines to Buy
August 25, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Step Aside Juno: World’s Richest Doctor Pulls Off Largest Biotech IPO Ever
July 29, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Bay Area’s Global Blood Therapeutics, Aimmune Jump on the IPO Wagon Seeking $115 Million Each
July 10, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Seres Therapeutics Raises $133M for State’s Second-Largest Bio IPO, As Rival OpenBiome Grows
June 26, 2015
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
HanchorBio Prices IPO at NT$120 Ahead of Innovation Board Listing on May 29
May 26, 2026
 · 
3 min read
Press Releases
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)
May 22, 2026
 · 
6 min read
Press Releases
InMed Pharmaceuticals Amends Preferred Investment Options
May 19, 2026
 · 
1 min read
Press Releases
Mobia Medical Announces Pricing of Initial Public Offering
May 8, 2026
 · 
2 min read
Press Releases
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
May 8, 2026
 · 
4 min read
Press Releases
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
 · 
2 min read
Press Releases
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
 · 
2 min read
Press Releases
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
 · 
4 min read
Press Releases
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
 · 
4 min read
Press Releases
Avalyn Announces Pricing of Upsized Initial Public Offering
April 29, 2026
 · 
4 min read
Press Releases
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 21, 2026
 · 
2 min read
Press Releases
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 17, 2026
 · 
2 min read
Press Releases
Integrant Awarded Nasdaq Ticker “INGT” Ahead of Highly Anticipated IPO
April 16, 2026
 · 
2 min read
Press Releases
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
April 10, 2026
 · 
5 min read
Press Releases
Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading
March 31, 2026
 · 
3 min read
Press Releases
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
March 10, 2026
 · 
1 min read
Press Releases
MiniMed announces pricing of initial public offering - March 5, 2026
March 5, 2026
 · 
5 min read
Press Releases
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
February 27, 2026
 · 
3 min read
Press Releases
MiniMed announces launch of IPO roadshow
February 24, 2026
 · 
6 min read
Press Releases
Agomab Announces Closing of Initial Public Offering
February 10, 2026
 · 
4 min read
Load More